Biofermin Pharmaceutical

Biofermin Pharmaceutical is a leading Japanese pharmaceutical company specializing in the research, development, and manufacturing of lactic acid bacteria-based products. Founded in 1917 and headquartered in Kobe, the company is best known for its flagship "Biofermin" brand, which has dominated the Japanese probiotic market for over a century. Their product portfolio includes over-the-counter (OTC) medicines, prescription drugs, and health foods designed to improve intestinal health and treat gastrointestinal disorders. As a subsidiary of Taisho Pharmaceutical, Biofermin continues to leverage its deep expertise in microbiology to innovate in the field of gut microbiome health. The company operates state-of-the-art manufacturing facilities in Kobe that adhere to strict GMP standards for microbial fermentation and stabilization.